Close X
Friday, September 20, 2024
ADVT 
International

Indian-origin Ramesh Balwani found guilty of defrauding investors, patients in US

Darpan News Desk IANS, 08 Jul, 2022 09:08 PM
  • Indian-origin Ramesh Balwani found guilty of defrauding investors, patients in US

San Francisco, July 8 (IANS) Indian-origin Ramesh 'Sunny' Balwani, the former business partner and 'boyfriend in secret' of Elizabeth Holmes, founder and CEO of healthcare company Therano, has been found guilty of defrauding Theranos investors and patients in the US.

Balwani faced 10 counts of wire fraud and two counts of conspiracy to commit wire fraud.

After a three-month trial, a jury has found him guilty of all 12 counts. He now faces up to 20 years in prison for each count, The Verge reported late on Thursday.

Youngest billionaire Holmes has already been found guilty of defrauding investors.

Indian-origin Balwani was Holmes' "boyfriend in secret".

"They met when Holmes was 18 and Balwani was 37 -- she moved in with him the year after she dropped out of Stanford. She also said during the trial that she was raped as a Stanford student, which is part of why she didn't finish her degree," according to an earlier TechCrunch report.

During the four months of court proceedings, Holmes detailed Balwani's controlling behaviour, including a written document that dictated her daily schedule, including what she ate, when she slept and how she dressed.

She said, "He was so disappointed in my mediocrity and he was trying to teach me how to be better."

Holmes founded Theranos in 2003 and the company was once valued at more than $9 billion.

In 2015, an expose in The Wall Street Journal revealed major problems with Theranos' technology.

In 2018, Holmes and Balwani were charged with two counts of conspiracy to commit wire fraud and nine counts of wire fraud.

According to the US Department of Justice, Holmes and Balwani used advertisements and solicitations to encourage and induce doctors and patients to use Theranos's blood testing laboratory services, even though, according to the government, the defendants knew Theranos was not capable of consistently producing accurate and reliable results for certain blood tests.

"It is further alleged that the tests performed on Theranos technology were likely to contain inaccurate and unreliable results," the Justice Department said.

Holmes and Balwani defrauded doctors and patients by making false claims concerning Theranos's ability to provide accurate, fast, reliable, and cheap blood tests and test results, and by omitting information concerning the limits of and problems with Theranos' technologies.

MORE International ARTICLES

Reputation of AstraZeneca's COVID vaccine marred by missteps

Reputation of AstraZeneca's COVID vaccine marred by missteps
In Norway, a top official warned on Monday it might not be able to resume its use of the vaccine because so many people were rejecting it.

Reputation of AstraZeneca's COVID vaccine marred by missteps

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Will you need a 'vaccine passport' to travel?
It is not clear, however, whether any of the passports under development will be accepted broadly around the world, and the result could be confusion among travellers and disappointment for the travel industry.

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why Georgia attack spurs fears in Asian Americans
As details emerge, many members of the Asian American community see the Georgia killings as a haunting reminder of harassment and assaults that have been occurring from coast to coast.

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why countries are halting the AstraZeneca shot

EXPLAINER: Why countries are halting the AstraZeneca shot
Norway, Iceland, Bulgaria, Thailand, and Congo soon followed suit. On Saturday, Norwegian authorities reported that four people under age 50 who had gotten the AstraZeneca vaccine had an unusually low number of blood platelets.

EXPLAINER: Why countries are halting the AstraZeneca shot

WHO grants emergency authorization for J&J COVID vaccine

WHO grants emergency authorization for J&J COVID vaccine
In a statement, the U.N. health agency said “the ample data from large clinical trials” shows the J&J vaccine is effective in adult populations. The emergency use listing comes a day after the European Medicines Agency recommended the shot be given the green light across the 27-country European Union.

WHO grants emergency authorization for J&J COVID vaccine

Denmark pauses AstraZeneca vaccine jabs to probe blood clots

Denmark pauses AstraZeneca vaccine jabs to probe blood clots
Denmark's Health Authority said its decision was “based on a precautionary principle” and that one person who developed a blood clot after vaccination had died.

Denmark pauses AstraZeneca vaccine jabs to probe blood clots